- Home
- EHC vs HOLX Comparison
EHC vs HOLX Comparison
Compare EHC & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- HOLX
- Stock Information
- Founded
- EHC 1983
- HOLX 1985
- Country
- EHC United States
- HOLX United States
- Employees
- EHC N/A
- HOLX N/A
- Industry
- EHC Hospital/Nursing Management
- HOLX Medical Electronics
- Sector
- EHC Health Care
- HOLX Health Care
- Exchange
- EHC Nasdaq
- HOLX Nasdaq
- Market Cap
- EHC 12.4B
- HOLX 16.5B
- IPO Year
- EHC 1986
- HOLX 1990
- Fundamental
- Price
- EHC $114.93
- HOLX $74.10
- Analyst Decision
- EHC Strong Buy
- HOLX Hold
- Analyst Count
- EHC 8
- HOLX 15
- Target Price
- EHC $141.88
- HOLX $79.00
- AVG Volume (30 Days)
- EHC 889.1K
- HOLX 4.9M
- Earning Date
- EHC 10-29-2025
- HOLX 11-03-2025
- Dividend Yield
- EHC 0.66%
- HOLX N/A
- EPS Growth
- EHC 27.89
- HOLX N/A
- EPS
- EHC 5.29
- HOLX 2.49
- Revenue
- EHC $5,795,600,000.00
- HOLX $4,100,500,000.00
- Revenue This Year
- EHC $11.54
- HOLX $6.23
- Revenue Next Year
- EHC $8.79
- HOLX $5.37
- P/E Ratio
- EHC $21.75
- HOLX $29.76
- Revenue Growth
- EHC 11.13
- HOLX 1.74
- 52 Week Low
- EHC $87.85
- HOLX $51.90
- 52 Week High
- EHC $127.99
- HOLX $80.75
- Technical
- Relative Strength Index (RSI)
- EHC 34.66
- HOLX 70.04
- Support Level
- EHC $114.00
- HOLX $73.86
- Resistance Level
- EHC $119.27
- HOLX $74.28
- Average True Range (ATR)
- EHC 3.50
- HOLX 0.25
- MACD
- EHC -1.07
- HOLX -0.05
- Stochastic Oscillator
- EHC 38.15
- HOLX 29.07
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.